Inotropic and vasopressor agents.
D000628:Aminophylline / Q000494:pharmacology; D000631:Aminopyridines / Q000494:pharmacology; D000676:Amrinone; D000818:Animals; D001775:Blood Circulation / Q000187:drug effects; D002301:Cardiac Glycosides / Q000494:pharmacology; D002316:Cardiotonic Agents / Q000494:pharmacology*; D002395:Catecholamines / Q000494:pharmacology; D002415:Cats; D005934:Glucagon / Q000494:pharmacology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects; D009411:Nerve Endings / Q000502:physiology; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000502:physiology; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
D000631:Aminopyridines; D002301:Cardiac Glycosides; D002316:Cardiotonic Agents; D002395:Catecholamines; D010726:Phosphodiesterase Inhibitors; D014662:Vasoconstrictor Agents; D000628:Aminophylline; D005934:Glucagon; D000676:Amrinone